Co‐morbidities and co‐medications as confounders of cardioprotection—Does it matter in the clinical setting?
Sign Up to like & getrecommendations! Published in 2019 at "British Journal of Pharmacology"
DOI: 10.1111/bph.14839
Abstract: The translation of cardioprotection from robust experimental evidence to beneficial clinical outcome for patients suffering acute myocardial infarction or undergoing cardiovascular surgery has been largely disappointing. The present review attempts to critically analyse the evidence… read more here.
Keywords: confounders cardioprotection; morbidities medications; myocardial infarction; evidence ... See more keywords